|
CEP63 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.840400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.724500E-03 |
| Normal-vs-Stage2 |
1.140040E-01 |
| Normal-vs-Stage3 |
8.313900E-02 |
| Normal-vs-Stage4 |
3.260300E-03 |
| Stage1-vs-Stage2 |
8.160200E-01 |
| Stage1-vs-Stage3 |
9.737600E-01 |
| Stage1-vs-Stage4 |
1.344630E-01 |
| Stage2-vs-Stage3 |
8.174200E-01 |
| Stage2-vs-Stage4 |
2.304000E-01 |
| Stage3-vs-Stage4 |
1.126960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.781500E-03 |
| Normal-vs-AfricanAmerican |
3.726300E-02 |
| Normal-vs-Asian |
9.108600E-01 |
| Caucasian-vs-AfricanAmerican |
8.290400E-01 |
| Caucasian-vs-Asian |
5.665600E-01 |
| AfricanAmerican-vs-Asian |
5.333200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.557490E-04 |
| Normal-vs-Female |
6.271200E-01 |
| Male-vs-Female |
6.639000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.983600E-02 |
| Normal-vs-Extreme_Weight |
1.057790E-03 |
| Normal-vs-Obese |
9.243700E-02 |
| Normal-vs-Extreme_Obese |
4.095400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.910600E-01 |
| Normal_Weight-vs-Obese |
4.936800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.937600E-01 |
| Extreme_Weight-vs-Obese |
2.129600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.163800E-01 |
| Obese-vs-Extreme_Obese |
8.994600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.600600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.060400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.973800E-04 |
| Normal-vs-Age(81-100Yrs) |
6.954200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.209200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.728360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.111600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.538300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.335900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.627000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.584600E-03 |
| Normal-VS-Type2 PRCC |
4.766900E-04 |
| Normal-VS-KIRP CIMP |
1.643950E-01 |
| Normal-VS-Unclassified PRCC |
9.506400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.744770E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.429600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.449800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.699780E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.075800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.580400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.555380E-04 |
| Normal-vs-N1 |
3.002600E-01 |
| Normal-vs-N2 |
1.038940E-03 |
| N0-vs-N1 |
1.049250E-01 |
| N0-vs-N2 |
5.115200E-01 |
| N1-vs-N2 |
1.897000E-01 |
|
|
